| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/ANNONC/12.SUPPL_2.S153 |
| P698 | PubMed publication ID | 11762344 |
| P50 | author | Alessandra Mosca | Q38325907 |
| P2093 | author name string | M Poggio | |
| L Dogliotti | |||
| G Gorzegno | |||
| A Berruti | |||
| A Angeli | |||
| A Mosca | |||
| D Fontana | |||
| E Bollito | |||
| M Mari | |||
| M Torta | |||
| R Tarabuzzi | |||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | S153-7 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | Potential clinical value of circulating chromogranin A in patients with prostate carcinoma | |
| P478 | volume | 12 Suppl 2 |
| Q37536006 | A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone |
| Q39155556 | Carboplatin plus etoposide in heavily pretreated castration-resistant prostate cancer patients |
| Q38843394 | Chromogranin A as a valid marker in oncology: Clinical application or false hopes? |
| Q47668183 | Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers. |
| Q36691329 | Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer? |
| Q38399930 | Midkine is associated with neuroendocrine differentiation in castration-resistant prostate cancer |
| Q24657547 | Neuroendocrine differentiation in prostate cancer |
| Q82498285 | Putative tissue markers in prostate cancer |
| Q47615483 | Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the ‘Watchful Waiting’ Study |
| Q47615493 | Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study |
| Q85445453 | Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: results from an Italian biopsy cohort |
| Q38833670 | Transforming growth factor-β signaling induced during prostate cancer cell death and neuroendocrine differentiation is mediated by bone marrow stromal cells |
Search more.